Study: Failure to combat second-dose vaccine attrition could prolong the pandemic
Though more than 131 million Americans have received at least one dose of COVID-19 vaccine to date, public confusion and uncertainty about the importance of second doses and continued public health precautions threaten to delay a U.S. return to normalcy, according to Cornell-led research published April 28 in the
New England Journal of Medicine.
In a nationally representative survey of more than 1,000 American adults conducted in February, less than half of respondents said they believed the Moderna and Pfizer-BioNTech vaccines provided strong protection against COVID-19 a week or two after a second dose, consistent with guidance from the U.S. Centers for Diseases Control and Prevention (CDC), the researchers found. One-fifth believed the vaccines provided strong protection after only one dose, and another 36% were unsure.
FOX News national correspondent Bryan Llenas joins Special Report with the details
The latest data from the Centers for Disease Control and Prevention (CDC) indicates that nearly 38% of U.S. adults are fully vaccinated against COVID-19, but officials have warned about a portion of the 55% of those who have received their first dose skipping out on the second. According to a new study, those 8% who are skipping the second dose could be prolonging the pandemic.
The research, published Wednesday in the New England Journal of Medicine, focused on responses from 1,000 American adults who were asked about the vaccines in February. One-fifth of respondents indicated to the Cornell-led research team that they believed the Modern and Pfizer COVID-19 vaccines, each two-dose shots, provided strong protection after only one jab, while 36% said they were unsure. Less than half said they believed the shots provided strong protection a week or two after the second dose, according to a news rele
E-Mail
ITHACA, N.Y. - Though more than 131 million Americans have received at least one dose of COVID-19 vaccine to date, public confusion and uncertainty about the importance of second doses and continued public health precautions threaten to delay a U.S. return to normalcy, according to Cornell-led research published April 28 in the
New England Journal of Medicine.
In a nationally representative survey of more than 1,000 American adults conducted in February, less than half of respondents said they believed the Moderna and Pfizer-BioNTech vaccines provided strong protection against COVID-19 a week or two after a second dose, consistent with guidance from the U.S. Centers for Diseases Control and Prevention (CDC), the researchers found. One-fifth believed the vaccines provided strong protection after only one dose, and another 36% were unsure.
Date Time
Skipping second shot could prolong pandemic, study finds
Though more than 131 million Americans have received at least one dose of COVID-19 vaccine to date, public confusion and uncertainty about the importance of second doses and continued public health precautions threaten to delay a U.S. return to normalcy, according to Cornell-led research published April 28 in the New England Journal of Medicine.
In a nationally representative survey of more than 1,000 American adults conducted in February, less than half of respondents said they believed the Moderna and Pfizer-BioNTech vaccines provided strong protection against COVID-19 a week or two after a second dose, consistent with guidance from the U.S. Centers for Diseases Control and Prevention (CDC), the researchers found. One-fifth believed the vaccines provided strong protection after only one dose, and another 36% were unsure.
March 4, 2021
The pervasive effects of the COVID-19 pandemic can leave us all feeling powerless at times. Students in the course Engineering Processes for Environmental Sustainability (BEE 2510) took back some power during the fall semester by addressing critical problems related to pandemic.
Instructors Jillian Goldfarb, assistant professor of biological and environmental engineering in the College of Agriculture and Life Sciences (CALS), and Alex Maag, postdoctoral associate with Cornell’s Active Learning Initiative, assigned students to solve problems related to COVID-19, from the logistics of vaccine storage and transportation, to the disinfection of public spaces, and the sanitation and reuse of personal protective equipment (PPE).